Recon Strategy
Contact

Insights

Fifteen+ years of
healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

ESSENTIAL READING

  • Biopharma, Payers, Institutional

Outcomes Based Arrangements in Biopharma

Today’s advanced therapies target devastating diseases with high unmet need. Given the urgent medical need (and pressure from patient advocates), regulators increasingly must make decisions based on early, incomplete data when it comes to durability, real-world effectiveness, and cost-effectiveness – all while bearing costs that can exceed $1 million per patient.
  • Biopharma

A few thoughts about navigating biopharma macro scenarios

Planning biopharma strategies against a robust set of macro-scenarios will be crucial to mid- and long-term success. While historically these scenarios have revolved around targeted issues, the current challengescall for a more expansive - and likely more difficult - set of questions to be asked.
  • Biopharma, Payers, Providers, Medtech, Digital

Why the Best AI Won’t Win in Healthcare

As advanced AI becomes widely accessible, healthcare companies can no longer rely on superior technology alone for lasting advantage. Instead, they need a coherent AI strategy built around five interconnected choices. Harvard Business Review article.
Sector
All
NEJM opinion

Readmissions rate fallacy

  • Providers
Today’s piece in Kaiser Health News that hospitals' readmissions rates…

Read more

Clear Health Alliance: Debut of the for-profit HIV/AIDS special needs plan

  • Payers
Summary HIV Special Needs Plans (SNPs) offer extra layers of servic…

Read more

Rescuing the condition-focused ACO from CMS

  • Payers , 
  • Providers
Summary The case for an oncology ACO can be compelling but CMS rule…

Read more

Transitioning from patchwork to quilt: NY and PA’s path to integrating HIEs at the state level

  • Payers , 
  • Providers
Last month, NY and PA announced plans for how they will integrate data…

Read more

Heartland Health: Marching towards Kansas City with Mayo on its shoulder

  • Payers , 
  • Providers
Earlier this month, Heartland Health signed a deal with the Mayo Clini…

Read more

The Blues system and PHIXs: not standardizing on a single utility

  • Payers
BCBSMN has licensed the platform for its private health insurance exch…

Read more

Towers Watson’s bold move in private insurance exchanges: leapfrog Aon and leave Mercer’s alliance compromised

  • Payers
With its acquisition of Extend Health, Towers Watson has ensured that …

Read more

Big box retail as health insurance channel: thoughts on the Aetna-Costco deal

  • Payers
Summary Aetna has struck a deal to sell individual health insurance w…

Read more

SELECTED ENGAGEMENTS

Insight, put to work

Our published thinking is one half of the picture. These are representative client engagements, anonymized — each tagged by sector, so you can trace the path from perspective to practice.

  • Institutional

Strategy for Statewide Health Information Exchange

A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable

HIE, Health IT,

  • Medtech, Early Stage

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition

  • Institutional

University Trials

Large university wanting to dramatically increase its clinical research footprint

Keep up with Recon Strategy Insights
Get an email each time we publish a new article